Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia

Haematologica. 2024 Feb 29. doi: 10.3324/haematol.2023.283928. Online ahead of print.

Abstract

Not available.